Jan Fagerberg

Jan Fagerberg has served as our Chief Medical Officer since January 2019. From 2017 to December 2018, Dr. Fagerberg served as Senior Adviser at Fagerberg Oncology SA. From 2013 to 2017, Dr. Fagerberg served as Chief Medical Officer at SOTIO a.s. From 2012 to 2013, Dr. Fagerberg served as Vice President, Global Development and Managing Director at Amgen Research GmbH. Prior to then, he served as the Senior Vice President and Chief Medical Officer at Micromet A/G from 2009 to 2012, prior to its acquisition by Amgen. Dr. Fagerberg was Medical Director at TopoTarget from 2006 to 2009. Dr. Fagerberg held various positions of increasing responsibility at Roche from 1999 to 2006 in medical and clinical operations after ten years of oncology practice and academic translational immune-oncology research at Karolinska Hospital. Dr. Fagerberg holds an M.D. and Ph.D. from the Karolinska Institute.

Jan Fagerberg is the Chief Medical Officer at ENTEROME, based in Europe. With a background in Biotechnology, Jan Fagerberg has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.